chemicals

IMERYS and Omya entered into exclusive negotiations to form a technology Joint Venture

IMERYS and Omya entered into exclusive negotiations to form a technology Joint Venture

IMERYS S.A. and Omya AG are pleased to announce they have entered into exclusive negotiations to form a 50:50 technology Joint Venture to promote the research and development of Micro Fibrillated Cellulose (MFC) concerning a variety of applications and industries. The venture will combine the FiberLean TM technology platforms developed by each company into one entity, henceforth to be known as FiberLean Technologies.

The first commercial product available, which has already been granted a Food Contact Notification (FCN) by the US Food and Drug Administration, allows paper & packaging producers to improve quality and/or increase the mineral filler loading to achieve productivity gains and reduced costs. The commercialization of MFC is to be independently and separately undertaken by IMERYS and Omya commercial teams making the technology easily accessible to customers across various industries.

Micro and Nano Cellulosics are renewable, sustainable engineered materials with the potential to deliver exceptional performance and value to a wide range of industrial and consumer markets. FiberLean TM Technologies will expand its process and application technology to deliver such products and solutions

papnews logo

Edipap Srl | VAT IT09057310964 | Via Pordenone 13, 20132 - Milan - Italy | phone +39 02 21711614 | www.edipap.com | info@papnews.com

close and go back to site

Lost your password?

close and go back to site